• Guideline Summary
  • NGC:010418
  • 2013 Oct

Recommendations for drug therapies for relapsing-remitting multiple sclerosis.

  • Expert Commentary

Comparison of Multiple Sclerosis Guidelines Underscores Need for Collaboration

  • Guideline Summary
  • NGC:009075
  • 2012 Apr

Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis.

  • Guideline Summary
  • NGC:010519
  • 2014 Aug

Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.

  • Guideline Summary
  • NGC:009358
  • 2005 Dec (revised 2012 Mar)

EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) — revised report of an EFNS task force.

  • Guideline Summary
  • NGC:010002
  • 2006 Feb (revised 2013)

Guidelines for the diagnosis and management of multiple myeloma 2013.

Guidelines for the management of hemophilia.

  • Guideline Summary
  • NGC:010430
  • 2014 May

Alemtuzumab for treating relapsing–remitting multiple sclerosis.

  • Guideline Summary
  • NGC:010284
  • 2014 Jan

Teriflunomide for treating relapsing–remitting multiple sclerosis.